When to discontinue glucocorticoids in GCA? How to monitor disease activity?
When to discontinue glucocorticoids in patients with giant cell arteritis (GCA)? How to monitor the disease activity?
When to discontinue glucocorticoids in patients with giant cell arteritis (GCA)? How to monitor the disease activity?
In what situations should we perform further investigations in patients with sacral pain? Which patients with sacral pain should have imaging studies performed? How to choose among or what are the indications for radiography, CT, and MRI of the spine, respectively?
When should we urgently qualify a patient with back pain syndrome for surgery?
What management should be considered in patients with Raynaud phenomenon if treatment with calcium channel blockers has been ineffective?
When to introduce pharmacotherapy in patients with Raynaud phenomenon?
Should we perform capillaroscopy in every patient with Raynaud phenomenon?
What is the risk of a systemic connective tissue disease in persons with Raynaud phenomenon? Does the prognostic value of Raynaud phenomenon differ between women and men?
Should febuxostat be contraindicated in patients with cardiovascular disease? Can it be used as the drug of choice (instead of allopurinol) in long-term gout treatment?
What manifestations of giant cell arteritis are associated with a high risk of vision loss?
Should we treat hyperuricemia without clinically relevant gout?